SAN DIEGO, Dec. 17, 2015 /PRNewswire/ -- OncoSec
Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company
developing DNA-based intratumoral cancer immunotherapies, today
announced the Company consolidated its three previous offices into
one new headquarters and research facility, developed by Alexandria
Real Estate Equities, Inc., in Sorrento Mesa, San Diego. As a result of the Company's growth
over the past year, OncoSec moved into a new office that houses
over 50 employees and all of the Company's discovery research,
clinical, and administrative activities under one roof.
"This is an exciting time for OncoSec as we join the Sorrento
Mesa community and find a home in San
Diego, a city that is on the cutting edge of the life
science and biotech industries," said Punit
Dhillon, President and CEO of OncoSec. "This move allows for
greater efficiencies and interactions among our dedicated teams.
Our new facility enhances our development capabilities and provides
OncoSec with a base of operations that matches the magnitude of our
ambitions."
"We are proud of the robust biotech industry and its incredible
impact in California. It's
encouraging to see another biotech company join and further
strengthen the San Diego area,
bringing jobs and economic vitality to the region," said
Panorea Avdis, Director of the
California Governor's Office of
Business and Economic Development. "Not only are biotechs like
OncoSec enhancing California's
economy, they also play a greater role in advancing innovative
technologies to provide better care and treatment for patients
everywhere."
"OncoSec's stunning new headquarters was a result of a truly
collaborative effort between the Company and Alexandria. We are thrilled to welcome them to
our innovative tenant community," said Daniel Ryan, Executive Vice President, Regional
Market Director (San Diego) and
Strategic Operations of Alexandria Real Estate Equities, Inc. "The
new facility provides OncoSec with a sustainable and
environmentally friendly space that accommodates growth and
enhances their R&D operations. We look forward to continuing to
serve OncoSec's facility needs and support its efforts developing
targeted cancer therapies."
The new facility, located at 5820 Nancy Ridge Drive, was built
with environmental and green features in mind to reduce the
Company's carbon footprint. The 34,000 square foot building
features recycled materials, drought-tolerant vegetation, and a
recycled water irrigation system, which will lower the water
consumption impact and create an environment prepared to thrive in
Southern California's current
drought conditions.
OncoSec's research facility also integrates approximately 15,000
square feet of laboratory space with state-of-the-art equipment
required for Discovery Research activities. The design approach
incorporates laboratory benches, specialized rooms, and equipment
strategically positioned to maximize workflow, provide sufficient
ambulatory space, and minimize potential disruption to
research.
About OncoSec Medical Incorporated
OncoSec is a biotechnology company developing DNA-based
intratumoral immunotherapies with an investigational technology,
ImmunoPulse™, for the treatment of cancer. ImmunoPulse™ is designed
to enhance the local delivery and uptake of DNA-based
immune-targeting agents, such as IL-12. In Phase I and II clinical
trials, ImmunoPulse™ IL-12 has demonstrated a favorable safety
profile and evidence of anti-tumor activity in the treatment of
various skin cancers as well as the potential to initiate a
systemic immune response. OncoSec's lead program, ImmunoPulse™
IL-12, is currently in Phase II development for several
indications, including metastatic melanoma, squamous cell carcinoma
of the head and neck, and triple-negative breast cancer. In
addition to ImmunoPulse™ IL-12, the Company is also identifying and
developing new immune-targeting agents for use with the
ImmunoPulse™ platform. For more information, please
visit www.oncosec.com.
Contact:
Mary
Marolla
OncoSec Medical Incorporated
855-662-6732
media@oncosec.com
Photo - http://photos.prnewswire.com/prnh/20151217/296971
Logo -
http://photos.prnewswire.com/prnh/20120905/LA68078LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/oncosec-opens-new-headquarters-and-research-facility-in-san-diego-300194693.html
SOURCE OncoSec Medical Incorporated